Xenon Pharmaceuticals XENE Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's current ratio?
- Xenon Pharmaceuticals (XENE) reported current ratio of 27.8× in Q1 2026.
- How has Xenon Pharmaceuticals's current ratio changed year-over-year?
- Xenon Pharmaceuticals's current ratio increased by 57.4% year-over-year, from 17.7× to 27.8×.
- What is the long-term trend for Xenon Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's current ratio has grown at a 1.8% compound annual growth rate (CAGR), from 12.3× to 13.4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.